home.social

#earningsguidance — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #earningsguidance, aggregated by home.social.

  1. Gilead Sciences shares dropped 1.5% after hours as the pharmaceutical giant slashed its full-year guidance to a net loss of $0.65-$1.05 per share from previous profit expectations of $8.45-$8.85, citing increased R&D and financing costs from recent major transactions.
    #YonhapInfomax #GileadSciences #EarningsGuidance #NetLoss #ResearchAndDevelopment #AfterHoursTrading #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  2. Gilead Sciences shares dropped 1.5% after hours as the pharmaceutical giant slashed its full-year guidance to a net loss of $0.65-$1.05 per share from previous profit expectations of $8.45-$8.85, citing increased R&D and financing costs from recent major transactions.
    #YonhapInfomax #GileadSciences #EarningsGuidance #NetLoss #ResearchAndDevelopment #AfterHoursTrading #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  3. Gilead Sciences shares dropped 1.5% after hours as the pharmaceutical giant slashed its full-year guidance to a net loss of $0.65-$1.05 per share from previous profit expectations of $8.45-$8.85, citing increased R&D and financing costs from recent major transactions.
    #YonhapInfomax #GileadSciences #EarningsGuidance #NetLoss #ResearchAndDevelopment #AfterHoursTrading #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  4. Gilead Sciences shares dropped 1.5% after hours as the pharmaceutical giant slashed its full-year guidance to a net loss of $0.65-$1.05 per share from previous profit expectations of $8.45-$8.85, citing increased R&D and financing costs from recent major transactions.
    #YonhapInfomax #GileadSciences #EarningsGuidance #NetLoss #ResearchAndDevelopment #AfterHoursTrading #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  5. ARM Holdings shares tumbled 6.7% in after-hours trading despite beating Q1 guidance, as the chip designer's forecast of flat to negative growth in its core mobile segment disappointed investors riding high on AI-driven expectations, with the stock reversing early gains to close at $221.23.
    #YonhapInfomax #ARMHoldings #MobileSegment #EarningsGuidance #NegativeGrowth #AfterHoursTrading #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  6. ARM Holdings shares tumbled 6.7% in after-hours trading despite beating Q1 guidance, as the chip designer's forecast of flat to negative growth in its core mobile segment disappointed investors riding high on AI-driven expectations, with the stock reversing early gains to close at $221.23.
    #YonhapInfomax #ARMHoldings #MobileSegment #EarningsGuidance #NegativeGrowth #AfterHoursTrading #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  7. ARM Holdings shares tumbled 6.7% in after-hours trading despite beating Q1 guidance, as the chip designer's forecast of flat to negative growth in its core mobile segment disappointed investors riding high on AI-driven expectations, with the stock reversing early gains to close at $221.23.
    #YonhapInfomax #ARMHoldings #MobileSegment #EarningsGuidance #NegativeGrowth #AfterHoursTrading #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  8. ARM Holdings shares tumbled 6.7% in after-hours trading despite beating Q1 guidance, as the chip designer's forecast of flat to negative growth in its core mobile segment disappointed investors riding high on AI-driven expectations, with the stock reversing early gains to close at $221.23.
    #YonhapInfomax #ARMHoldings #MobileSegment #EarningsGuidance #NegativeGrowth #AfterHoursTrading #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  9. South Korea’s construction sector is showing signs of rebounding from undervaluation, with major firms’ strong earnings and low price-to-book ratios drawing investor interest, despite lingering uncertainties around key projects.
    #YonhapInfomax #ConstructionSector #HyundaiEngineeringAndConstruction #SamsungEA #PriceToBookRatio #EarningsGuidance #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  10. Molina Healthcare Inc. raised in pre-market trading after cutting its annual earnings outlook due to rising medical costs, with its CEO stating the US budget bill will not impact the company's long-term prospects.
    #YonhapInfomax #MolinaHealthcare #EarningsGuidance #MedicalCosts #PreMarket #BudgetBill #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  11. Synopsys withdrew its full-year earnings guidance after receiving a US Commerce Department letter restricting exports to China, highlighting rising US-China tech tensions and intensifying competition in the Chinese semiconductor market.
    #YonhapInfomax #Synopsys #EarningsGuidance #USExportControls #ChinaSemiconductor #SharePriceDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV